Hand gestures to support expression for autistic and language‑impaired people in rural areas

Rural Autistic Individuals - Supporting Expression

Not applicable Interventional Montana State University · NCT07054866

This research tests whether gestures adapted from American Sign Language help people with autism, developmental language disorders, or related conditions in rural communities understand and communicate words better.

Quick facts

PhaseNot applicable
Study typeInterventional
Enrollment50 (estimated)
Ages2 Years and up
SexAll
SponsorMontana State University Academic / other
Locations1 site (Bozeman, Montana)
Trial IDNCT07054866 on ClinicalTrials.gov

What this trial studies

Participants wear non‑invasive neuroimaging gear (EEG and fNIRS simultaneously) and have their eye movements recorded while watching pictures and videos pairing spoken words with hand gestures adapted from ASL. Tasks include passive computer viewing of object pictures with matching speech and gestures, optional picture‑book tasks to probe comprehension and problem solving if the participant can engage, and questionnaires for caregivers or adult participants. The EEG requires scalp electrodes with gel and participants wear a cloth helmet with sensors; fNIRS measures blood flow through the scalp. Data will be used to see whether gesture+speech combinations improve neural and behavioral markers of word comprehension in people from rural communities.

Who should consider this trial

Good fit: Ideal candidates are people age 2 and up who live in rural areas, have confirmed or suspected autism spectrum disorder or receptive language impairment (or are typically developing controls), have normal or corrected hearing and vision, and have caregivers who speak English.

Not a fit: People with significant hearing loss, inborn or acquired brain damage, or those unable or unwilling to travel to the testing site are unlikely to benefit or be eligible.

Why it matters

Potential benefit: If successful, families could learn practical gesture techniques to improve word understanding and everyday communication for children and adults with language difficulties in rural areas.

How similar studies have performed: Previous behavioral studies have shown that gestures can aid word learning and comprehension in children and some autistic individuals, but combining ASL‑derived gestures with simultaneous EEG and fNIRS in rural populations is relatively novel.

Eligibility criteria

Show full inclusion / exclusion criteria
Inclusion Criteria:

* 1.1 Confirmed (preferably) or suspected diagnosis of ASD (autism spectrum disorder), or a receptive language impairment (i.e., difficulties with comprehension, Developmental Language Disorder), or both. Additional diagnoses, including ADHD (Attention Deficit and Hyperactivity Disorder), are acceptable. Siblings and cousins of these individuals are also welcome.

OR 1.2 No diagnoses of ASD or DLD for unrelated control typically-developing participants.

2\. Normal hearing and normal vision (or corrected to normal with glasses or contacts).

3\. Ages 2+. 4. English as the dominant language of caregivers. 5. Caregivers who self-identify as living in a rural area. 6. The ability to verbally or physically respond is optional.

Exclusion Criteria:

* 1\. Poor hearing. 2. Inborn or acquired brain damage.

Where this trial is running

Bozeman, Montana

Study contacts

How to participate

  1. Review the eligibility criteria above with your treating physician.
  2. Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
  3. Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions Autism DisorderLanguage Development DisordersADHDTypical DevelopmentRural HealthChildrenNeuroimagingEye Tracking
Last reviewed 2026-06-13 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.